Public trial registry of the CCC-Munich

Trial COEB071X2101

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
COEB071X2101
World
Full title
:

An Open-Label, Single-arm, Phase I study of AEB071 (aProtein Kinase C Inhibitor) in Patients with CD79-mutantDiffuse Large B-Cell Lymphoma

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
KUM - Med3 - Medizinische Klinik und Poliklinik III Lmu
Indications
Classification Code Description
ICD-10-GM C81-C96 Bösartige Neubildungen des lymphatischen, blutbildenden und verwandten Gewebes, als primär festgestellt oder vermutet
Trial design
World
Trial type
:
Interventional
World
Phase
:
I
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Positive
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.